Ignorance leads to opportunity – at least that’s the theory of one London-based fund manager, who has singled out the biotechnology sector as offering some of the best growth stocks on his Australian watch list.

The fundie, who declined to be named, said the potential advantage comes about because the Australian investor “just doesn’t get it". It’s a harsh but fairly true assessment, say analysts who cover the beat.